Chevy Chase Trust’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Chevy Chase Trust's ABMD Position: Q4 2022 in Review
Chevy Chase Trust sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 27,758 shares — an estimated $6.82M sold.
Chevy Chase Trust first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $16.6M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Chevy Chase Trust reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Chevy Chase Trust sold 27,758 Abiomed Inc shares in Q4 2022, an estimated $6.82M.
- Chevy Chase Trust first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
- Chevy Chase Trust's Abiomed Inc position peaked at $16.6M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Chevy Chase Trust's 13F filing for Q4 2022, filed 9 Feb 2023.